SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2405)12/28/2000 12:32:17 AM
From: Scott H. Davis  Respond to of 52153
 
The TA may not be so OT. There was once a thriving thread on SI called The Rational Analyst where investors\analysts from multiple investment disciplines combined to look at stocks from the business case, FA, macroeconomics & TA at the same time.

If you are trying to accumulate a position in a biotech with the aid of volitility, then recognizing overbought & oversold conditions, support & resistance are usefull tools.

Clinical effectivenes, market potential, agreement terms, FA, management effectiveness, regulatory climate are all discussed here.

Occasional TA would surely be less off-topic then political discussions, would it not?

IMSCO Scott



To: Jibacoa who wrote (2405)1/12/2001 11:43:24 AM
From: Jibacoa  Read Replies (2) | Respond to of 52153
 
SQNM: Keeps doing well. It is up 49.25% since my comment of Dec.27 at the 13 1/2 level.

It seems ready to test the resistance at the 21 1/2 area.It is up 2 13/16 today.

Bernard